Samsung DR system gets FDA nod

Samsung NeuroLogica has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its GC70 digital radiography (DR) system, expanding the company's suite of radiography products in the U.S.

GC70 includes new digital enhancements such as the company's S-Vue imaging engine, which delivers high-resolution images through adaptive filtering, Samsung said. Workflow enhancements such as S-Align offer accurate alignment at multiple angles and broadcast the detector's degree of angulation to the tube head, allowing proper radiographic alignment when imaging patients on a gurney or in a wheelchair, the firm said.

In addition, a four-axis individual blade control function reduces unnecessary radiation dose by enabling more precise collimation -- an especially useful feature for pediatric chest exams, Samsung said.

The system's lightweight, wireless S-detectors are offered in multiple sizes, making GC70 adaptable for use with patients of different ages and sizes. Tailored configurations of the scanner enable providers to use it in a variety of settings such as dedicated chest rooms, outpatient clinics, and orthopedic practices, Samsung said.

Page 1 of 376
Next Page